Rising regulatory approvals, increasing biologics pipelines, and escalating expenditure in upcoming-generation peptide modalities continue on for making 2025 a pivotal growth 12 months for your industry.> Phoenix Pharmaceuticals has operated for more than thirty decades, creating deep connec